Becton Dickinson and Co

BDX59

S&P500

$224.00arrow_drop_down0.65%-$1.46

S&P500

BDX59

$224.00

arrow_drop_down0.65%-$1.46

S&P500

Performance History

Key Stats
Open	$225.46
Prev. Close	$225.45
EPS	5.92

Next Earnings Date	Jan 2, 2025

	LOW	HIGH
Day Range	225.09	225.81
52 Week Range	218.75	269.51

Ratios







EPS	5.92

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Becton Dickinson and Co (BDX)

Becton Dickinson and Co (BDX) is a global medical technology company that specializes in the development, manufacture, and sale of medical devices, instrument systems, and reagents. The company's products are used in hospitals, clinics, laboratories, and other healthcare settings to improve patient outcomes and enhance healthcare delivery. With a rich history dating back to its founding in 1897, Becton Dickinson has established itself as a leader in the healthcare industry.

The stock price history of Becton Dickinson and Co (BDX) reflects its strong performance and growth over the years. The company has consistently delivered positive financial results and has demonstrated its ability to adapt to changing market dynamics. Investors have been rewarded with steady stock price appreciation and the payment of regular dividends.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Thomas E. Polen Jr.
Headquarters: Franklin Lakes
Employees: 77000
Exchange: NYSE

add Becton Dickinson and Co to watchlist

Keep an eye on Becton Dickinson and Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Becton Dickinson and Co's (BDX) price per share?

The current price per share for Becton Dickinson and Co (BDX) is $224. The stock has seen a price change of -$1.47 recently, indicating a -0.65% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Becton Dickinson and Co (BDX)?

For Becton Dickinson and Co (BDX), the 52-week high is $269.52, which is 20.32% from the current price. The 52-week low is $218.75, the current price is 2.4% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Becton Dickinson and Co (BDX) a growth stock?

Becton Dickinson and Co (BDX) has shown an average price growth of -6.03% over the past three years. It has received a score of 43 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Becton Dickinson and Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Becton Dickinson and Co (BDX) stock price performance year to date (YTD)?

As of the latest data, Becton Dickinson and Co (BDX) has a year-to-date price change of -8.73%. Over the past month, the stock has experienced a price change of -6.87%. Over the last three months, the change has been -4.62%. Over the past six months, the figure is -4.62%. Looking at a longer horizon, the five-year price change stands at -10.03%.

help

Is Becton Dickinson and Co (BDX) a profitable company?

Becton Dickinson and Co (BDX) has a net income of $1.73B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 45.36% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 15.19% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $20.18B, with a revenue growth rate of 4.16%, providing insight into the company's sales performance and growth. The gross profit is $9.15B. Operating income is noted at $2.42B. Furthermore, the EBITDA is $4.91B.

help

What is the market capitalization of Becton Dickinson and Co (BDX)?

Becton Dickinson and Co (BDX) has a market capitalization of $65.08B. The average daily trading volume is 224.24, indicating the stock's liquidity and investor engagement.

News

Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology

Global Life Science and Chemical Instruments Market Set to Reach USD 79.7 Billion by 2034, Projected to Grow at 5.3% CAGR | Future Market Insights, Inc.

BD Board Increases Dividend for 53rd Consecutive Year

[Latest] Global Cancer Cell Analysis Market Size/Share Worth USD 23.31 Billion by 2033 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Germany Home Healthcare Market Forecast Report 2024-2032 - Rising Adoption of Telehealth Services, Focus on Patient-Centric Care and Emphasis on Preventive Care

GUIDEWIRES

MINIMALLY INVASIVE PROCEDURES

TECHNOLOGICAL ADVANCEMENTS

MEDICAL DEVICES

Nov 4, 2024

Global Guidewires Market Poised for Significant Growth: Surge in Minimally Invasive Procedures and Technological Advancements Drive Market toward USD 6,885.7 million by 2034 | FMI

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

About Becton Dickinson and Co (BDX)

Keep an eye on Becton Dickinson and Co

Frequently Asked Questions

What is Becton Dickinson and Co's (BDX) price per share?

What is the 52-week high and low for Becton Dickinson and Co (BDX)?

Is Becton Dickinson and Co (BDX) a growth stock?

What is Becton Dickinson and Co (BDX) stock price performance year to date (YTD)?

Is Becton Dickinson and Co (BDX) a profitable company?

What is the market capitalization of Becton Dickinson and Co (BDX)?

News

Take Your Investments to a Whole New Level